Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 10, 2015 - Issue
Submit an article Journal homepage
119
Views
9
CrossRef citations to date
0
Altmetric
Review

Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD

Anoop Prakash1 Department of Respiratory Medicine, Castle Hill Hospital, Cottingham, UKCorrespondence[email protected]
,
K Suresh Babu2 Department of Respiratory Medicine, Queen Alexandra Hospital, Cosham, Portsmouth, UK
&
Jaymin B Morjaria1 Department of Respiratory Medicine, Castle Hill Hospital, Cottingham, UK;3 Department of Academic Respiratory Medicine, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, UK
Pages 111-123 | Published online: 07 Jan 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Evgenios I. Metaxas & Evangelos Balis. (2018) The safety of indacaterol for the treatment of COPD. Expert Opinion on Drug Safety 17:6, pages 637-642.
Read now

Articles from other publishers (8)

Astrid Bacle, Guillaume Bouzillé, Arnaud Bruyère, Marc Cuggia, Olivier Fardel & Pascal Le Corre. (2021) Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans. European Journal of Pharmaceutics and Biopharmaceutics 164, pages 36-53.
Crossref
Myrna B. Dolovich, Andreas Kuttler, Thomas J. Dimke & Omar S. Usmani. (2019) Biophysical model to predict lung delivery from a dual bronchodilator dry-powder inhaler. International Journal of Pharmaceutics: X 1, pages 100018.
Crossref
Monika Chabicovsky, Swantje Winkler, Michael Soeberdt, Ana Kilic, Clarissa Masur & Christoph Abels. (2019) Pharmacology, toxicology and clinical safety of glycopyrrolate. Toxicology and Applied Pharmacology 370, pages 154-169.
Crossref
Jennifer C. Samp, Min J. Joo, Glen T. Schumock, Gregory S. Calip, A. Simon Pickard & Todd A. Lee. (2017) Comparative Effectiveness of Long-Acting Beta 2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:4, pages 447-455.
Crossref
Michael H. Chiu, Nawaf S. Al-Majed, Ryan Stubbins, Dylan Pollmann & Roopinder K. Sandhu. (2016) A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use. BMC Research Notes 9:1.
Crossref
Thierry Troosters, Jean Bourbeau, François Maltais, Nancy Leidy, Damijan Erzen, Dorothy De Sousa, Lawrence Korducki & Alan Hamilton. (2016) Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design. BMJ Open 6:4, pages e010106.
Crossref
Bryony Coupe, Andrew L. Griffiths & Gwyneth A. Davies. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 153 164 .
K. Suresh Babu & Jaymin B. Morjaria. (2015) Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 9:2, pages 56-68.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.